Gülçin Babaoğlu

Dr. Gülçin Babaoğlu

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2019 in Cephalalgia
Verified
Journal Article
Closed access
LILevent Ertugrul Inan
Levent Ertugrul Inan
NINurten Inan
Nurten Inan
HUHanzade Aybuke Unal-Artık
Hanzade Aybuke Unal-Artık
CACeyla Atac
Ceyla Atac
GBGülçin Babaoğlu
Gülçin Babaoğlu
Objectives: The importance and popularity of peripheral nerve block procedures have increased in the treatment of migraine. Greater occipital nerve (GON) block is a commonly used peripheral nerve block method, and there are numerous researches on its use in migraine treatment.Materials and methods: A search of PubMed for English-language randomized controlled trials (RCT) and open studies on greater occipital nerve block between 1995 and 2018 was performed using greater occipital nerve, headache, and migraine as keywords.Results: In total, 242 potentially relevant PubMed studies were found. A sum of 228 of them which were non-English articles and reviews, case reports, letters and meta-analyses were excluded. The remaining articles were reviewed, and 14 clinical trials, seven of which were randomized-controlled on greater occipital nerve block in migraine patients, were identified and reviewed.Conclusions: Although clinicians commonly use greater occipital nerve block in migraine patients, the procedure has yet to be standardized. The present study reviewed the techniques, drugs and dosages, the frequency of administration, side effects, and efficacy of greater occipital nerve block in migraine patients.

1 January 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
ZKZafer Yasin Konya
Zafer Yasin Konya
STSuna Akin Takmaz
Suna Akin Takmaz
HBHülya Başar
Hülya Başar
BBBülent Baltaci
Bülent Baltaci
GBGülçin Babaoğlu
Gülçin Babaoğlu
The aim of this study was to investigate the medium- to long-term effects of radiofrequency (RF) ablation of genicular nerves for chronic refractory knee pain due to osteoarthritis (OA). Forty-eight patients who underwent RF ablation of the genicular nerves were evaluated retrospectively. The visual analogue scale (VAS) score, Western Ontario and McMaster universities osteoarthritis index (WOMAC index), opioid and nonsteroidal antiinflammatory drug (NSAID) use score, quality of life score, and treatment satisfaction score were examined at 1, 3, and 6 months after the procedure. The mean VAS scores were significantly lower at the 1-, 3-, and 6-month evaluations compared with the preoperative values (P < 0.001). A significant decrease was observed in the WOMAC index compared with preoperative values (P < 0.001). It was found that 66.7% of opioid users and 56.3% of NSAID users stopped using medication. No serious complications were encountered during or after the procedure. In chronic refractory knee pain due to OA, the application of RF ablation to the genicular nerve is an effective and safe treatment option in the medium to long term.

20 June 2025 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
GBGülçin Babaoğlu
Gülçin Babaoğlu
Sukriye DadaliSukriye Dadali
Sukriye Dadali
ÜSÜLKÜ SABUNCU
ÜLKÜ SABUNCU
EAErkan Yavuz Akçaboy
Erkan Yavuz Akçaboy
ŞÇŞeref Çeli̇k
Şeref Çeli̇k
ŞŞŞazi̇yE Şahi̇n
Şazi̇yE Şahi̇n
Background/aim: We aimed to evaluate the effectiveness of distal versus proximal greater occipital nerve (GON) pulsed radiofrequency (PRF) treatments in patients with episodic or chronic migraine. Materials and methods: In this prospective, randomized controlled study, sixty participants were randomized to either distal GON PRF (n= 30) or proximal GON PRF (n = 30). Migraine related assessments were conducted at the baseline and at the first, second, and third month. Results: Baseline characteristics indicated a higher migraine burden in the proximal group, including increased monthly headache frequency (15.0 vs. 9.5 attacks, p = 0.007). Both groups experienced significant reductions in headache duration, severity and frequency over three months (Friedman test, p < 0.001). Notably, the proximal group experienced greater reductions in severe headache frequency at all time points (1st month: p = 0.004; 3rd month: p = 0.022) and total headache days by the third month (14.0 vs. 9.5 days, p = 0.039). The distal group exhibited some advantages in reducing headache severity (VAS), showing a trend toward improvement in the second month (p = 0.055) and achieving statistical significance by the third month (p = 0.011). No unexpected adverse effects were observed in either group. Conclusion: Both treatments were well-tolerated, with minimal adverse effects. Our findings indicate that both proximal and distal approaches are safe and effective for migraine management. The proximal approach might offer slightly superior outcomes for patientsexperiencing severe and frequent migraine attacks.

23 June 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
GBGülçin Babaoğlu
Gülçin Babaoğlu
BKBanu Kiliçaslan
Banu Kiliçaslan
AYAysun Ankay Yilbaş
Aysun Ankay Yilbaş
BÇBilge Çelebi̇oĞlu
Bilge Çelebi̇oĞlu
Background/aim: Knowledge regarding pain relief during labor remains insufficient. We aimed to determine and compare the effectiveness and safety of epidural analgesia, combined spinal-epidural analgesia, and parenteral meperidine on both mothers and fetuses. Materials and methods: This study was designed as an observational case-control study. We collected prospective data from patients whose labor pain management was conducted with meperidine in addition to retrospective cohort data of neuraxial methods; 138 patients were enrolled. Epidural analgesia group consisted of 68 patients, whereas combined spinal-epidural (CSE) analgesia group and meperidine group consisted of 50 and 20 patients, respectively. We compared the delivery patterns, labor durations, pain levels, side effects, maternal satisfaction levels, and neonatal outcomes of the various pain management methods. Results: Patient demographics, duration of first, second, and third labor stages, and instrumental delivery rates were comparable among groups (P > 0.05). Cesarean section tended to be less frequent in the CSE group. In the meperidine group, visual analog scale (VAS) values and sedation were significantly higher (P < 0.001) and maternal satisfaction lower (P < 0.001). Hypotension tended to be more frequent in the meperidine group. APGAR scores at the 1st and 5th min were similar among the groups and between meperidine subgroups defined by three different administration times (4 h; P > 0.05). Conclusion: Neuraxial methods had no effect on instrumental delivery rates. CSE represented a near significant risk reduction in cesarean section. Our results demonstrated that regional analgesia methods were reasonably safe for both mother and fetus, and regional analgesia methods resulted in greater maternal satisfaction and pain control compared to meperidine.

6 February 2026 in Medicine
Verified
Journal Article
Open access
GBGülçin Babaoğlu
Gülçin Babaoğlu
ÜSÜLKÜ SABUNCU
ÜLKÜ SABUNCU
Sukriye DadaliSukriye Dadali
Sukriye Dadali
AÇAli Çoştu
Ali Çoştu
EAErkan Yavuz Akcaboy
Erkan Yavuz Akcaboy
Coccydynia is a chronic pain syndrome with a complex pathophysiology. While ganglion impar blockade (GIB) is an effective treatment, predictors of response are not well-established. This study aimed to evaluate whether hematologic inflammatory indices or coccygeal morphology could predict the clinical response to GIB in patients with chronic coccydynia. We retrospectively reviewed the records of 119 patients who underwent GIB. Demographics, pain characteristics, coccygeal morphology (Postacchini–Massobrio classification), and preprocedural indices were extracted from the medical records. The primary outcome at the 1-month follow-up was a response, defined as either a ≥50% reduction in the visual analog scale pain score or a global perceived effect (GPE) score ≥ 6. Hematologic indices and coccygeal morphology were analyzed to assess their ability to discriminate between responders and nonresponders at 1 month after GIB. The overall response rate was 62.2%, with a significantly higher rate observed in females compared to males ( P = .02). Responders had significantly higher baseline platelet-to-lymphocyte ratio (PLR; P = .006) and systemic immune-inflammation index (SII; P = .023), whereas other indices did not differ. Receiver operating characteristic analysis showed moderate discrimination for PLR (area under the curve = 0.650) and SII (area under the curve = 0.621). While overall coccygeal morphology was not associated with response ( P = .25), types III and V were significantly associated with a higher rate of nonresponse ( P = .048). GIB is an effective treatment for chronic coccydynia. Pre-procedural PLR and SII may serve as accessible biomarkers to identify patients more likely to benefit, while coccygeal types III and V may be associated with poorer outcomes.

8 July 2026 in Medicina
Verified
Journal Article
Open access
PDF file
ÜSÜLKÜ SABUNCU
ÜLKÜ SABUNCU
GBGülçin Babaoğlu
Gülçin Babaoğlu
Sukriye DadaliSukriye Dadali
Sukriye Dadali
AÇAli Çoştu
Ali Çoştu
NBNevcihan SAHUTOGLU BAL
Nevcihan SAHUTOGLU BAL
EAErkan Yavuz Akcaboy
Erkan Yavuz Akcaboy
Background and Objectives: Predicting treatment response following transforaminal epidural steroid injection (TFESI) in older adults with lumbar radicular pain (LRP) remains challenging. Hematological inflammatory indices have been proposed as accessible biomarkers; however, their clinical utility remains uncertain. This study aimed to evaluate the predictive value of preprocedural hematological inflammatory indices and determine whether clinical variables provide a more clinically relevant framework for predicting TFESI outcomes. Materials and Methods: This retrospective observational study included 190 patients aged ≥65 years who underwent TFESI for LRP. Pain intensity was assessed using the Numeric Rating Scale (NRS) at baseline and after 3 months. Treatment response was defined as a ≥50% reduction in the NRS (meaningful pain response, [MPR-50]). Pre-procedural hematological parameters and derived indices, including the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI), were calculated. The pain phenotype was categorized as nociceptive, neuropathic, or mixed using the Douleur Neuropathique 4 (DN4) scale. Univariate and multivariable logistic regression analyses were performed, and receiver operating characteristic (ROC) analysis was used to assess the discriminative performance. Results: A meaningful pain response was achieved in 61.1% of the patients. Lymphocyte and monocyte counts were higher in responders; however, effect sizes were small. Importantly, patients with neuropathic pain exhibited significantly higher monocyte counts, SIRI, and AISI, indicating an association between pain phenotype and systemic inflammatory burden; however, these markers were not associated with treatment response. Furthermore, isolated inflammatory indices demonstrated limited standalone discriminative performance in the ROC analysis. In the adjusted hematological model, NLR demonstrated a modest statistical association with MPR-50; however, this association weakened in the final integrated model. Conclusion: Inflammatory indices and pain phenotypes may reflect biological and clinical heterogeneity in older adults with LRP; however, their standalone predictive value for TFESI outcomes appears limited. TFESI responsiveness is likely multifactorial and may be better evaluated using an integrated clinical framework.
1